FISA DE PREZENTARE DR NICOLETA MARIANA BERBEC ...

olilor cromozomiale rare (2006 – in derulare) – membru in echipa de
cercetare a INCD “Victor Babes”.
Am participat ca subinvestigator la următoarele studii clinice internationale:
1. CML 8 – Multicenter Open, Randomized Study, Comparing Therapy
with Inteferon α-2b (Intron A) with Continous vs. Intermitent
Addition of the Study Drug YNK-01 (Cytosyne arabinoside, Oral) in
the Treatment of Chronic Myeloid Leukemia – perioada studiului
2000-2004. Subinvestigator.
2. IL 2006 – A Phase 2 Randomized, Open Label, Controlled Trial of the
addition of 8 weeks Subcutaneous (SC) Administration of Aldeleukin
(rh-Interleukin·2[IL·2]) to 4 weeks Intravenous (IV) Administration of
Rituximab (Rituxan·, MabThera·) in the Treatment of Rituximab
Naive Subjects with Follicular Non-Hodgkin’s Lymphoma,
Refractory or Relapsed after Previous Chemotherapy – perioada 2005-
2006. Subinvestigator.
3. BO 17072 / CLL Mabthera – perioada 2004 – in prezent.
Subinvestigator.
4. NHL13 - Rituximab in B-cell NHL – perioada 2006 – in prezent.
Subinvestigator.
5. XM01-22 (nonplatinum chemotherapy / solid tumours and nonmyeloid
haematological tumours). Efficacy and safety of XM01
compared to placebo in patients with solid tumours or non-mieloid
haematological tumours receiving nonplatinum chemotherapy. A
multinational, multicentre, randomised, placebo-controlled, doubleblind,
parallel-groupe phase III study. Perioada – 2006 – in prezent.
Investigator.
6. XM01-23 - Efficacy and safety of XM01 compared to placebo in
anaemic patients with low grade non-Hodgkin’s lymphoma, chronic
lymphocytic leukemia or multiple myeloma receiving anticancer
therapy. Perioada – 2006 – in prezent. Subinvestigator